Global Gastroesophageal Reflux Disease Therapeutics Market Size, Status and Forecast 2025

Publisher Name :
Date: 12-Jun-2018
No. of pages: 98
Inquire Before Buying

This report studies the global Gastroesophageal Reflux Disease Therapeutics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Gastroesophageal Reflux Disease Therapeutics market by companies, region, type and end-use industry.

In 2017, the global Gastroesophageal Reflux Disease Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered

AstraZeneca

Eisai

Takeda Pharmaceutical

GlaxoSmithKline

Johnson & Johnson

Daewoong Pharmaceutical

Ironwood Pharmaceuticals

Rottapharm Madaus

Peer Medical

Reviva Pharmaceuticals

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Market segment by Type, the product can be split into

Antacids

H2 Receptor Blockers

Proton Pump Inhibitors (PPIs)

Pro-kinetic Agents

Others

Market segment by Application, split into

Hospital Pharmacy

Drug Stores

General Stores

Supermarkets

The study objectives of this report are:

To study and forecast the market size of Gastroesophageal Reflux Disease Therapeutics in global market.

To analyze the global key players, SWOT analysis, value and global market share for top players.

To define, describe and forecast the market by type, end use and region.

To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Gastroesophageal Reflux Disease Therapeutics are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Gastroesophageal Reflux Disease Therapeutics Manufacturers

Gastroesophageal Reflux Disease Therapeutics Distributors/Traders/Wholesalers

Gastroesophageal Reflux Disease Therapeutics Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Gastroesophageal Reflux Disease Therapeutics market, by end-use.

Detailed analysis and profiles of additional market players.

Global Gastroesophageal Reflux Disease Therapeutics Market Size, Status and Forecast 2025

Table of Contents
Global Gastroesophageal Reflux Disease Therapeutics Market Size, Status and Forecast 2025
1 Industry Overview of Gastroesophageal Reflux Disease Therapeutics
1.1 Gastroesophageal Reflux Disease Therapeutics Market Overview
1.1.1 Gastroesophageal Reflux Disease Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Gastroesophageal Reflux Disease Therapeutics Market by Type
1.3.1 Antacids
1.3.2 H2 Receptor Blockers
1.3.3 Proton Pump Inhibitors (PPIs)
1.3.4 Pro-kinetic Agents
1.3.5 Others
1.4 Gastroesophageal Reflux Disease Therapeutics Market by End Users/Application
1.4.1 Hospital Pharmacy
1.4.2 Drug Stores
1.4.3 General Stores
1.4.4 Supermarkets
2 Global Gastroesophageal Reflux Disease Therapeutics Competition Analysis by Players
2.1 Gastroesophageal Reflux Disease Therapeutics Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 AstraZeneca
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.2 Eisai
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.3 Takeda Pharmaceutical
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.4 GlaxoSmithKline
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.5 Johnson & Johnson
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.6 Daewoong Pharmaceutical
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.7 Ironwood Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.8 Rottapharm Madaus
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.9 Peer Medical
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
3.10 Reviva Pharmaceuticals
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) (2013-2018)
4 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type and Application (2013-2018)
4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2013-2018)
4.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
4.3 Potential Application of Gastroesophageal Reflux Disease Therapeutics in Future
4.4 Top Consumer/End Users of Gastroesophageal Reflux Disease Therapeutics
5 United States Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
5.1 United States Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
5.2 United States Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
5.3 United States Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
6 Europe Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
6.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
6.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
6.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
7 China Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
7.1 China Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
7.2 China Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
7.3 China Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
8 Japan Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
8.1 Japan Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
8.2 Japan Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
8.3 Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
9 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
9.1 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
9.2 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
10 India Gastroesophageal Reflux Disease Therapeutics Development Status and Outlook
10.1 India Gastroesophageal Reflux Disease Therapeutics Market Size (2013-2018)
10.2 India Gastroesophageal Reflux Disease Therapeutics Market Size and Market Share by Players (2013-2018)
10.3 India Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size (Value) by Regions (2018-2025)
11.1.1 United States Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.1.2 Europe Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.1.3 China Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.1.4 Japan Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.1.5 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.1.6 India Gastroesophageal Reflux Disease Therapeutics Revenue and Growth Rate (2018-2025)
11.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size (Value) by Type (2018-2025)
11.3 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2018-2025)
12 Gastroesophageal Reflux Disease Therapeutics Market Dynamics
12.1 Gastroesophageal Reflux Disease Therapeutics Market Opportunities
12.2 Gastroesophageal Reflux Disease Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Gastroesophageal Reflux Disease Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Gastroesophageal Reflux Disease Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions (2013-2018)
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type in 2017
Figure Antacids Market Size (Million USD) and Growth Rate (2013-2018)
Figure H2 Receptor Blockers Market Size (Million USD) and Growth Rate (2013-2018)
Figure Proton Pump Inhibitors (PPIs) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Pro-kinetic Agents Market Size (Million USD) and Growth Rate (2013-2018)
Figure Others Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application in 2017
Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in Hospital Pharmacy (2013-2018)
Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in Drug Stores (2013-2018)
Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in General Stores (2013-2018)
Figure Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate in Supermarkets (2013-2018)
Table Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table AstraZeneca Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of AstraZeneca (2013-2018)
Figure AstraZeneca Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Eisai Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Eisai (2013-2018)
Figure Eisai Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Takeda Pharmaceutical Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Takeda Pharmaceutical (2013-2018)
Figure Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
Figure GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
Figure Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Daewoong Pharmaceutical Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Daewoong Pharmaceutical (2013-2018)
Figure Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Ironwood Pharmaceuticals Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Ironwood Pharmaceuticals (2013-2018)
Figure Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Rottapharm Madaus Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Rottapharm Madaus (2013-2018)
Figure Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Peer Medical Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Peer Medical (2013-2018)
Figure Peer Medical Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Reviva Pharmaceuticals Basic Information List
Table Gastroesophageal Reflux Disease Therapeutics Business Revenue (Million USD) of Reviva Pharmaceuticals (2013-2018)
Figure Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Business Revenue Market Share (2013-2018)
Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Product (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Product (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Share by Product in 2017
Table Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Gastroesophageal Reflux Disease Therapeutics
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table United States Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure United States Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure United States Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table China Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table China Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure China Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure China Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) and Growth Rate (2013-2018)
Table India Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Players (2013-2018)
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2013
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size Share by Players in 2017
Table India Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2013-2018)
Figure India Gastroesophageal Reflux Disease Therapeutics Revenue Market Share (%) by Application (2013-2018)
Figure India Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application in 2017
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size and Growth Rate (2018-2025)
Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Regions (2018-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share (2018-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Regions in 2025
Figure United States Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Gastroesophageal Reflux Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Type (2018-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Type in 2018
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Type in 2025
Table Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Application (2018-2025)
Figure Global Gastroesophageal Reflux Disease Therapeutics Market Size (Million USD) by Application in 2018
  • Global Molecular Biology Enzymes and Kits & Reagents Market Insights, Forecast to 2025
    Published: 16-Jan-2019        Price: US 4900 Onwards        Pages: 112
    The key factors driving the growth of this market include increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases & genetic disorders. The highest growth rate of the APAC market is attributed to increasing government interest in the biomedical & biotechnology industries, the presence of bio-clusters in India and China, and growing o......
  • Global Microplate Systems Market Insights, Forecast to 2025
    Published: 16-Jan-2019        Price: US 4900 Onwards        Pages: 122
    This market is experiencing significant growth due to increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. In 2017, North America is expected to account for the largest share of the market followed by Europe. The global Microplate Systems market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The ......
  • Global Microbiome Sequencing Services Market Insights, Forecast to 2025
    Published: 16-Jan-2019        Price: US 4900 Onwards        Pages: 114
    The rising use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS) are the major factors driving the growth of the global microbiome sequencing services. The pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR in the market in 2016. The global Microbiome Sequencing Services market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing......
  • Global Medical Tubing Market Insights, Forecast to 2025
    Published: 16-Jan-2019        Price: US 4900 Onwards        Pages: 115
    The increase in aging population is a key driver for the medical tubing market, as the major demand for feeding tubes, fluid management, drainage tubes, and ventilator tubes are driven by the aged population. Drug delivery system is expected to be the fastest-growing market for medical tubing. The global Medical Tubing market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study ......
  • Global Medical Tapes and Bandages Market Insights, Forecast to 2025
    Published: 16-Jan-2019        Price: US 4900 Onwards        Pages: 121
    Factors such as the rising number of surgeries, increasing incidence of chronic wounds, and rising geriatric population are driving the growth of the medical tapes and medical bandages market. Asia-Pacific is expected to register the highest growth rate during the forecast period mainly due to rising population, which is aging and affected with diabetes making them prone to chronic diseases and conditions which require surgical intervention. The global Medical Tapes and Bandages ma......
  • Global Medical Sensors Market Insights, Forecast to 2025
    Published: 16-Jan-2019        Price: US 4900 Onwards        Pages: 118
    The medical sensors market is projected to grow rapidly due to the increasing incidences of cancer, acute myocardial infarction, and diabetes mellitus as well as the increasing number of postoperative rehabilitation patients across the globe. The market in APAC is expected to grow at the highest rate, followed by the Rest of the world. The global Medical Sensors market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% dur......
  • Global Medical Radiation Shielding Market Insights, Forecast to 2025
    Published: 16-Jan-2019        Price: US 4900 Onwards        Pages: 114
    The growth of this market is mainly driven by factors such as growing incidences of cancer, increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment of Cancer, increasing number of diagnostic imaging centers and installation bases of radiology equipment. Geographically, the medical radiation shielding market is dominated by North America, followed by Europe, Asia, and the Rest of the World. The global Medical Radiation Shielding market is valued at xx ......
  • Global Medical Radiation Detection, Monitoring & Safety Market Insights, Forecast to 2025
    Published: 16-Jan-2019        Price: US 4900 Onwards        Pages: 111
    Growth in the medical radiation detection, monitoring, and safety market is mainly driven by factors such as increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, growing worldwide prevalence of cancer. Growth in the North American segment is primarily driven by the increasing awareness about radiation safety; increasing number of radio-diagnostic procedures; and ongoing research aimed at the development of new and advanced radiation detection, monitoring......
  • Global Medical Membranes Market Insights, Forecast to 2025
    Published: 16-Jan-2019        Price: US 4900 Onwards        Pages: 119
    The demand for medical membranes is expected to increase in the near future, owing to the rising prevalence of ESRD, globally. The medical membranes market in APAC is projected to grow at the highest CAGR between 2017 and 2022. The global Medical Membranes market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Medical Mem......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs